Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- FDA Moves Against Unapproved Obesity Drugs
- The FDA has published a list of unapproved, "tainted," or "undeclared" weight-loss drugs that it wants off the market. The list includes rimonabant and sibutramine. Rimonabant was the active ingredient in Zimulti/Acomplia, the ill-fated obesity treatment that Sanofi-Aventis tried to get approved in the U.S. The FDA turned the application...
- Blog posts 2009-01-09
Additional Resources
- St. Luke's plans to join Meridia. (planned merger between Meridia Health System and St. Luke's Medical Center)
- One more for Meridia? Hospitals involved in potential merger Numbers as of Nov. '94 Beds Bassinets St. Luke's Medical Center Shaker Boulevard in Cleveland ...
- Research articles 1995-03-13
- Polk ready to operate; Blue Cross, Meridia choose ex-COSE chief to direct joint venture. (John Polk; Blue Cross and Blue Shield of Ohio; Meridia Health Systems; Council of Smaller Enterprises)
- John Polk, who made a name for himself as a buyer of health care for the Council of Smaller Enterprises, now will be packaging medical services as the new head of a joint venture between Blue Cross & Blue Shield of Ohio and the Meridia Health SysteJohn...
- Research articles 1995-04-10
- Meridia union adds to Clinic's clout in market. (Meridia Health System; Cleveland Clinic)
- The Meridia Health System's decision to pursue a union with the Cleveland Clinic signifies the emergence of a health care monolith likely to use its muscle to exert bargaining clout over insurers and other health care players. The question that ...
- Research articles 1996-10-07
- Walters: top Blue Cross execs swayed Meridia vote. (University Hospitals Health Systems CEO Farah M. Walters; Blue Cross and Blue Shield of Ohio executives; Meridia Health System)
- The head of the University Hospitals Health Systems said four top executives of Blue Cross & Blue Shield of Ohio, its opponent in multiple lawsuits, provided the swing votes that turned the Meridia Health System into the hands of the Cleveland ClinThe head of the University Hospitals...
- Research articles 1996-10-21
- Hospitals declare merger deal dead. (St. Luke's Medical Center; Meridia Health Systems)
- St. Luke's Medical Center and the Meridia Health System have called off merger talks just four months after acknowledging publicly they were in discussions. Officials at both hospitals last week declined to elaborate on what triggered the suspension oSt. Luke's Medical Center and the Meridia Health...
- Research articles 1995-07-24
- Abbott Laboratories is working with Italian and European authorities to confirm the safety of Meridia/Reductil (sibutramine). (Active Pharmaceutical Ingredient Watch).(Brief Article)
- ABBOTT Laboratories is working with Italian and European authorities to confirm the safety of Meridia/Reductil sibutramine. Italy has suspended the sale of ... ABBOTT Laboratories is working with Italian and European authorities to confirm the safety of Meridia/Reductil sibutramine. Italy has suspended the...
- Research articles 2002-03-18
- FDA delays action on Meridia petition
- The FDA has delayed taking any action on a petition seeking the withdrawal of Abbott Laboratories' weight-loss drug Meridia sibutramine on safety grounds. The FDA's director of drugs, Janet Woodcock, recently wrote Public Citizen Health Research Group Director Sidney Wolfe informing him that the agency had not yet completed its...
- Research articles 2002-12-01
- FDA watches Meridia reports after deaths in Italy
- The FDA said in March that it is monitoring Abbott Laboratories' European adverse event reports involving the use of weight-loss drug Meridia sibutramine, which is called Reductil overseas, following temporary marketing suspension ordered by the Italian Health Ministry, reportedly because two patients died after taking the medication. In addition, Italian...
- Research articles 2002-05-01
- FDA decision on Meridia expected in fall
- Abbott executives say that the FDA will need more than the 90 days allowed to respond to a March-filed petition from Public Citizen's Sidney Wolfe asking that the company's weight loss drug Meridia be withdrawn from the market. In a June 11 conference call with financial analysts, Abbott Pharmaceutical Products...
- Research articles 2002-08-01
- Hospitals win right to build care centers. (Meridia Hillcrest Hospital; Mt. Sinai Medical Center)
- Hospitals win right to build care centers Officials at Meridia Hillcrest Hospital and Mt. Sinai Medical Center last week negotiated settlement agreements with the Ohio Department of Health allowing both hospitals to go ahead with proposed construction projects for outpatient-care centers in Cleveland's ...
- Research articles 1991-05-20
- Kenneth B. Moll & Associates, Ltd. are Investigating Claims of Deaths and Serious Injuries as a Result of the Potentially Deadly Diet Drug Meridia Which is Manufactured by Abbott Laboratories and Knoll Pharmaceuticals
- Business Editors/Legal Writers
- Research articles 2002-03-20
- Weighing in; Xenical, Meridia use motivating advertising to prod overweight Americans to action.(Brief Article)
- Pharmaceutical companies are reaping the fat of the land. In 1999, the anti-obesity prescription drug market generated revenues of $338.6 million, showing a startling growth rate of 80.6% from the previous year, according to marketing consultant Frost & Sullivan. Although that...
- Research articles 2000-04-03
- Just a minor glitch - No Comment
- Despite receiving a warning from the Food and Drug Administration for failing to report the death of a user of its diet medicine Meridia and depite inaccurately reporting serious side effects attributed to three other drugs, Abbott Laboratories told the Associated Press that the violations raise no questions about the...
- Research articles 2002-10-01
- Wyeth Ventures Into Obesity Drug Graveyard
- Wyeth will pay $120 million to Thiakis to obtain its anti-obesity drug candidate, TKS1225. In doing so, Wyeth has taken its first, expensive step into a disease category that many drug companies have entered, and all have failed. Obesity is a classic graveyard of failed drug brands. There's a good...
- Blog posts 2008-12-22
- Vivus Beating Arena, Orexigen In Obesity Graveyard Race
- The race to produce a blockbuster anti-obesity pill -- a contest that no company has yet won -- got interesting this week with the news, via AP, that Arena Pharmaceuticals' data showed that its contender, lorcaserin, showed only 3.6 percent more effectiveness than a placebo. The FDA wants to see...
- Blog posts 2009-03-31
- Arena Lays Off 31% of Its Staff Following Obesity Trial Failure
- Arena Pharmaceuticals is to lay off 31 percent, or 130 employees, before June 22, the company told the SEC. Arena staffers -- whose future is dependent on an anti-obesity drug, lorcaserin -- may be forgiven for wondering how it has all gone wrong so quickly. In February, Arena CEO...
- Blog posts 2009-04-27
- CHIEF EXEC ON DECK: STRAUSS SOON TO BE AT SUMMA HELM.
- If all goes according to plan, Akron's Summa Health System will undergo a smooth management transition come Jan. 28. That's when Thomas J. Strauss, 47, an executive seasoned with the former Meridia Health System, will succeed Albert Gilbert as Summa's president and chief...
- Research articles 1999-10-04
- Meridian Gold Reports Third Quarter 2002 Results (All dollar amounts in U.S. currency).
- RENO, NEVADA, Oct 22, 2002 CCNMatthews via COMTEX Highlights * El Penon gold production of 78,000 ounces at a cash cost of $43 per ounce * Net income of $9.2 million, or $0.10 per share * Unhedged...
- Research articles 2002-10-23
- Meridian Gold Reports First Quarter 2003 Results.
- RENO, NEVADA, May 8, 2003 CCNMatthews via COMTEX (All dollar amounts in U.S. currency) Highlights - El Penon gold production of 85,000 ounces at a cash cost of $44 per ounce - Net income of $8.8 million, or $0.09...
- Research articles 2003-05-08
- << Previous
- page 1 of 1
- Next >>
